Business
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its annual 2024 financial results and provide a company update after the market closes on Tuesday, March 4, 2025.
About this update from Cumberland Pharmaceuticals Inc.
[{"type":"text","content":"NASHVILLE, Tenn., Feb. 25, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its annual 2024 financial results and provide a company update after the market closes on Tuesday, March 4, 2025.","length":287,"tagName":"p"},{"type":"image","alt":"Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)","displaySize":"","headline":null,"caption":"Cumberland Pharmaceuticals Logo (PRNewsFoto/Cumberland Pharmaceuticals Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":85,"url":"https://media.zenfs.com/en/prnewswire.com/d6491f4600abd2c969a7073e33e75676"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OuxLa.Ojx9Ti0awbVjPq0w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1MDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d6491f4600abd2c969a7073e33e75676","width":400,"height":85}},"href":"https://mma.prnewswire.com/media/84325/cumberland_pharmaceuticals_logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"A conference call will be held on March 4 at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please register at https://register.vevent.com/register/BIafb49dfab9014db59440ff63e1d827b2.","length":211,"tagName":"p"},{"type":"text","content":"Once registered, participants can dial in from their phone using a dial-in and PIN number that will be provided to them. Alternatively, they can choose a "Call Me" option to have the system automatically call them at the start of the conference.","length":255,"tagName":"p"},{"type":"text","content":"A replay of the call will be available for one year and can be accessed via Cumberland's website or by visiting https://edge.media-server.com/mmc/p/r4puvzy9/.","length":162,"tagName":"p"},{"type":"text","content":"Cumberland Pharmaceuticals is a specialty pharmaceutical company focused on providing unique products that improve patient care. The company develops, acquires, and commercializes products for the hospital acute care, gastroenterology and oncology market segments.","length":269,"tagName":"p"},{"type":"text","content":"The company's portfolio of FDA-approved brands includes:","length":60,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Acetadote® (ac...